Japan's Kirin cashes out of Amgen drug joint venture

TOKYO (Reuters) - Japan's Kirin Holdings Co Ltd said on Tuesday it would sell its share in a pharmaceutical research joint venture with California-based drugmaker Amgen Inc for $780 million.

Japan's Kirin cashes out of Amgen drug joint venture
Read More


Bagikan Berita Ini